Navigation Links
Elsevier Launches Evidence-Based, Collaborative Order Sets Solution
Date:2/25/2013

PHILADELPHIA, February 25, 2013 /PRNewswire/ --

InOrder is designed to improve patient outcomes and meaningful use attestation by providing intuitive authoring, superior usability and high quality content

Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced the launch of InOrder, an intuitive, cloud-based order sets solution that enables clinicians to author, review and publish orders in a collaborative environment that quickly translates evidence-based knowledge into better patient care.

"InOrder combines a highly efficient, easy-to-use content management workflow solution for hospitals' content development and technology teams, with hundreds of evidence-based, highly usable order sets that can be used 'out of the box' or customized as needed," said Dr. Jonathan Teich , Elsevier's Chief Medical Informatics Officer. "InOrder's localization feature allows users to create order sets from their hospital preferences by incorporating orderable items directly from their existing EHRs, including their current workflows and terminologies."

By combining Elsevier's deep experience in providing evidence-based content and the capability to make updates rapidly as regulations and medications change, InOrder can help hospitals and clinicians increase patient safety and prevent medical errors.

"Evidence-based order sets facilitate best practices in diagnosis and treatment, thereby enabling healthcare organizations to improve care quality, support standardization, and achieve meaningful use," said Nancy Fabozzi , Principal Analyst, Frost & Sullivan. "Providers will value a well-designed, technology-enabled solution based on trusted content that leverages proprietary clinical systems, workflows, and terminologies that are designed to accelerate product implementation, integration, usability, and clinician acceptance."

Without integrated systems in place to support efficient order set creation and review, hospitals and health systems often can take months to create or update a single order set. Without understanding and streamlining the communications among multiple authors and approvers, insufficient order set systems can languish and fail despite the best efforts of the contributors.

"I strongly believe that an advanced order set solution can lead to improvements in patient care," said Carol Steltenkamp , Chief Medical Information Officer, University of Kentucky HealthCare, an InOrder beta customer. "We were eager to implement InOrder by Elsevier because it streamlines the entire process of creating, managing and maintaining order sets, and ensuring that all order sets are based on current evidence-based information and best practices."

InOrder includes:

  • Access to relevant evidence-based answers from ClinicalKey, Elsevier's clinical insight engine
  • Advanced collaboration tools for order set development, maintenance, access and tracking
  • Tailored, concise ordering focused on the most common scenarios
  • Availability across technology platforms enabled by a cloud-based delivery model
  • Localization tools to incorporate hospitals' clinical terminologies and import existing order sets
  • Enhanced clinical guidance and evidence within the set
  • Quality metric indicators that highlight orders important for guidelines and metrics

"We developed InOrder with our customers top-of-mind and a goal of providing a superior solution that would positively impact patient care and support physician workflow," said Jay Katzen , president of Elsevier's clinical solutions business. "Our focus was on delivering a quality, metrics-driven system that was easy for clinicians to use. Clinicians will have the flexibility to manage their own workflow and order sets, access content that includes CDS guidance and regular updates, and utilize a layout based on the way they think and work."

For a demonstration of InOrder, and to learn more about Elsevier, visit them at HIMSS13 (March 3-7) in New Orleans at booth #6129. A complete list of demonstrations and Elsevier presentations at HIMSS can be found be at http://www.clinicaldecisionsupport.com/himss13.

# # #

About Elsevier

Elsevier is a world-leading provider of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet and Cell, and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier's online solutions include ScienceDirect, Scopus, Reaxys, ClinicalKey and Mosby's Suite, which enhance the productivity of science and health professionals, and the SciVal suite and MEDai's Pinpoint Review, which help research and health care institutions deliver better outcomes more cost-effectively.

A global business headquartered in Amsterdam, Elsevier employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC, a world leading provider of professional information solutions in the Science, Medical, Legal and Risk and Business sectors, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).


'/>"/>
SOURCE Elsevier
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. The Elsevier Foundation, TWAS, and OWSD Honor Early Career Women Scientists in Developing Countries at the Annual AAAS Meeting
2. Elsevier Announces the Launch of a New Journal: Journal of Forensic Radiology and Imaging
3. Elsevier and Kanazawa University in Japan Collaborate to Map Universitys Research Performance
4. Elsevier Welcomes New Editor-in-Chief for European Urology
5. Dr. Peter C. Neligan, Author of 3rd Edition of Elseviers Plastic Surgery Text, Available for Comment on the Contributions of Dr. Joseph Murray
6. Elsevier and the Dutch Fulbright Center Start Collaboration to Support Early Career Researchers in the Netherlands
7. Elsevier Offers Entire Collection of Journals and Books to Innovators in Developing Countries Through the Access to Research for Development and Innovation (ARDI) Program
8. Elsevier Acquires ExitCare, Provider of Patient Education Solutions
9. Elsevier Collaborates With Infocomm Development Authority of Singapore and Top Academic Institutions to Bring CodeForScience to Singapore
10. Elsevier / Gold Standard Announces New Drug Class Overviews for Clinical Pharmacology
11. Elsevier / MEDai Names Dr. Peter Edelstein as Chief Medical Officer and Dr. Gerald Osband as Director of Product Strategy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2016)... ... , ... Bulk food product inspection systems are specifically designed ... the production process. Despite frequently inspecting loose product prior to packaging, product inspection ... sacks of dry powders. , Mettler-Toledo Product Inspection's brand-new white paper entitled "Improving ...
(Date:2/8/2016)... the development of future natural products for crop protection. In ... center in Israel and invests substantial ... has a variety of products adapted to regional needs, ... than 35 counties worldwide. ... Gold ® is used to control a broad spectrum ...
(Date:2/6/2016)... McLean, VA (PRWEB) , ... February 06, 2016 , ... ... enrichment session, cost-free, for middle and high school teachers on Wednesday February 10, 2016. ... be held at the Smithsonian-Mason School of Conservation, located at 1500 Remount Road in ...
(Date:2/5/2016)... , Feb. 5, 2016  In the pharmaceutical industry ... a host of launch activities including the identification and ... launch activity is especially high in the oncology therapeutic ... Best Practices and the Role of Medical Affairs in ... focused on oncology therapies find better ways to utilize ...
Breaking Biology Technology:
(Date:1/13/2016)... 2016 http://www.researchandmarkets.com/research/7h6hnn/india_biometrics ... the  "India Biometrics Authentication & Identification ...  report to their offering.  ... the addition of the  "India Biometrics ... & Forecast (2015-2020)"  report to ...
(Date:1/8/2016)... MANCHESTER, United Kingdom , Jan. 8, 2016 /PRNewswire/ ... sensor-based diagnostic products, today announced the closing of a $9 ... investors.  Proceeds from the financing will be used to accelerate ... device for detecting early-stage pressure ulcers. ... after receiving CE Mark approval. The device,s introduction has been ...
(Date:1/7/2016)... 2016 Various factors have contributed to ... as biologics and biosimilars. Some of these factors ... growing demand for cost-effective alternatives, growing burden of ... similar versions of their corresponding patented biologic drugs, ... safety, and efficacy. The global biosimilars market is ...
Breaking Biology News(10 mins):